EMERALD RESOURCES NL — Share Issue/Capital Change 2024

May 12, 2024

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

EMERALD RESOURCES NL

Announcement Type

New announcement

Date of this announcement

Monday May 13, 2024

The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B Total number of +securities to be quoted

ASX +security		Number of +securities to
code	Security description	be quoted	Issue date
EMR	ORDINARY FULLY PAID	1,808,346	13/05/2024

Refer to next page for full details of the announcement

Appendix 2A - Application for quotation of securities

1 / 8

Appendix 2A - Application for quotation of securities

Part 1 - Entity and announcement details

==> picture [21 x 22] intentionally omitted <==

1.1 Name of entity

EMERALD RESOURCES NL

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

Registration number

ACN 009795046

1.3 ASX issuer code

EMR

1.4 The announcement is

New announcement

1.5 Date of this announcement

13/5/2024

Appendix 2A - Application for quotation of securities

2 / 8

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

Previous Appendix 3B details:

Announcement Date and Announcement Title Selected Appendix 3B to submit quotation Time request 18-Aug-2023 08:35 New - Proposed issue of securities - A placement or other type of issue EMR

2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B? Yes

2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B

The Company has issued a Bidder's Statement to acquire all of the issued shares of Bullseye (that it does not already own) in a share based transaction.

Appendix 2A - Application for quotation of securities

3 / 8

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B

Placement Details

ASX +security code and description EMR : ORDINARY FULLY PAID

Issue date

13/5/2024

Distribution Schedule

Provide a distribution schedule for the new +securities according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities held by the recipients in each category.

category.
		Total percentage of +securities held
Number of +securities held	Number of holders	For example, to enter a value of 50%
		please input as 50.00
1 - 1,000		%
1,001 - 5,000		%
5,001 - 10,000		%
10,001 - 100,000		%
100,001 and over		%

Appendix 2A - Application for quotation of securities

4 / 8

Appendix 2A - Application for quotation of securities

Issue details

==> picture [21 x 22] intentionally omitted <==

Number of +securities to be quoted

1,808,346

Are the +securities being issued for a cash consideration?

No

Please describe the consideration being provided for the +securities

Bullseye shareholders who accepted the Offer will be issued with 1 Emerald share for every 4 Bullseye shares held.

Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted

3.600000

Any other information the entity wishes to provide about the +securities to be quoted

Appendix 2A - Application for quotation of securities

5 / 8

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

==> picture [540 x 710] intentionally omitted <==

Appendix 2A - Application for quotation of securities

6 / 8

Appendix 2A - Application for quotation of securities

Part 4 - Issued capital following quotation

==> picture [21 x 22] intentionally omitted <==

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

+securities subject of this application)
	Total number of
ASX +security code and description	+securities on issue
EMR : ORDINARY FULLY PAID	654,103,999
4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
	Total number of
ASX +security code and description	+securities on issue
EMRAR : OPTION EXPIRING 28-FEB-2029 EX $3.70	250,000
EMRAL : OPTION EXPIRING 14-MAR-2027 EX $1.32	350,000
EMRAQ : OPTION EXPIRING 12-SEP-2028 EX $2.84	2,270,000
EMRAH : OPTION EXPIRING 23-FEB-2026 EX $0.95	400,000
EMRAG : OPTION EXPIRING 04-JAN-2026 EX $0.82	125,000
EMRAE : OPTION EXPIRING 30-JUL-2025 EX 67C	3,250,000
EMRAM : OPTION EXPIRING 14-JUN-2027 EX $1.40	250,000
EMRAD : OPTION EXPIRING 19-MAY-2025 EX 53C	75,000
EMRAK : OPTION EXPIRING 29-JUL-2026 EX $1.09	3,037,500
EMRAC : OPTION EXPIRING 12-MAR-2025 EX 51C	350,000
EMRAJ : OPTION EXPIRING 03-MAY-2026 EX $1.02	75,000
EMRAO : OPTION EXPIRING 13-APR-2028 EX $1.94	1,000,000
EMRAP : OPTION EXPIRING 16-MAY-2028 EX $2.17	250,000
EMRAN : OPTION EXPIRING 17-OCT-2027 EX $1.37	2,300,000

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

Appendix 2A - Application for quotation of securities

7 / 8

Appendix 2A - Application for quotation of securities

500,000

==> picture [21 x 22] intentionally omitted <==

EMRAS : OPTION EXPIRING 21-MAR-2029 EX $3.51

Appendix 2A - Application for quotation of securities

8 / 8